It was suggested that miRNA-145 acts as a tumor suppressor by suppressing the expression of HIF-2α and VEGF, as well as upregulating AR-suppressed miRNA-145, by binding to AREs in the miRNA-145 gene at the promoter region. The gene discussed is EPAS1; the disease is neoplasm.